Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis

Eur Respir J. 2017 Feb 8;49(2):1602520. doi: 10.1183/13993003.02520-2016. Print 2017 Feb.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antifungal Agents*
  • Aspergillosis*
  • Chronic Disease
  • Humans
  • Lung Diseases, Fungal
  • Pulmonary Aspergillosis

Substances

  • Antifungal Agents